Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer
- 31 January 2005
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 96 (1), 132-135
- https://doi.org/10.1016/j.ygyno.2004.10.001
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Pilot study of outpatient paclitaxel, carboplatin and gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancerGynecologic Oncology, 2004
- Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2003
- Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group TrialJournal of Clinical Oncology, 2003
- Chronic Administration of Single-Agent Paclitaxel in Gynecologic MalignanciesGynecologic Oncology, 2001
- Second-Line Treatment of Ovarian CancerThe Oncologist, 2000
- Prolonged Disease-Free Survival by Maintenance Chemotherapy among Patients with Recurrent Platinum-Sensitive Ovarian CancerGynecologic Oncology, 1998
- A Phase II Trial of Intraperitoneal Cisplatin and Etoposide as Consolidation Therapy in Patients with Stage II–IV Epithelial Ovarian Cancer Following Negative Surgical AssessmentGynecologic Oncology, 1998
- Three-Hour Paclitaxel Infusion and Carboplatin Is an Effective Outpatient Treatment for Stage III Epithelial Ovarian CancerGynecologic Oncology, 1998
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- A Prospective Randomized Comparison of 6 and 12 Cycles of Cyclophosphamide, Adriamycin, and Cisplatin in Advanced Epithelial Ovarian Cancer: A Danish Ovarian Study Group Trial (DACOVA)Gynecologic Oncology, 1993